The Pharmacy Compounding Advisory Committee narrowly recommended BPC-157, KPV, TB-500, MOTS-c, Semax, and epitalon for the 503A Bulks List.
Dosing & Delivery Innovations
Advertisement
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, explains how GLP-1-based therapies are reshaping diabetes, obesity, and cardiometabolic care and what that means for coverage decisions.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Senate Unveils Sweeping Bill to Reform 340B Drug Program
2
Gene Therapy for Wet AMD Near an Inflection Point: Arshad Khanani, MD
3
Brexpiprazole and Dextromethorphan-Bupropion: Mechanisms of Action and Key Clinical Trial Data for Approved Alzheimer's Disease Agitation Therapies
4
JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD
5